Asian Journal Of Social Pharmacy

Abstract: Objective To provide reference for China’s medical insurance reimbursement plan of multi-indication drugs. Methods By referring to relevant foreign literature, the implementation process and conditions of different reimbursement management modes of multi-indication drugs were analyzed to provide suggestions for reimbursement of multi-indication drugs in China. Results and Conclusion It is suggested to further explore the suitable conditions and select the corresponding mode in China. Payment standards should be set according to value pricing and budget impact analysis. Besides, data collection and analysis mechanism must be improved. Lastly, reward and punishment mechanism can be adopted to improve management efficiency.

Key words: multi-indication drug, medical insurance reimbursement, payment standard